Genmab | GEN - Biaya Operasional

Harga Saham
1,690.00
Perubahan Harian
35.00 2.11%
Bulanan
-1.34%
Tahunan
20.80%
Q2 Perkiraan
1,628.53




Biaya Operasional Perubahan Tanggal
Agios Pharmaceuticals USD 130.77M 10.77M 2026-03
Almirall EUR 517.4M 32K 2025-12
Amarin USD 51.48M 113K 2025-12
Amgen USD 5.9B 773M 2025-12
argenx SE USD 914.57M 137.58M 2025-12
AstraZeneca USD 8.18B 4.35B 2026-03
Bayer EUR 10.33B 126M 2025-12
BioMarin Pharmaceutical USD 676.18M 131.65M 2025-12
Demant DKK 9.63B 241M 2025-12
Exelixis USD 362.75M 21.35M 2025-12
Fresenius Medical Care EUR 4.41B 27.91M 2025-12
Galapagos EUR 120.26M 7.43M 2025-12
Genmab DKK 798M 235M 2025-12
GlaxoSmithKline GBP 5.34B 1.85B 2026-03
GN Store Nord DKK 4.11B 490M 2025-12
GRIFOLS EUR 1.71B 193M 2025-12
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Insmed USD 513.55M 109.86M 2025-12
Lonza CHF 2.9B 184M 2025-06
Merck EUR 4.78B 669M 2025-12
Novartis USD 9.8B 61M 2025-12
Regeneron Pharmaceuticals USD 31.42B 28.44B 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 9.31B 1.2B 2026-03
UCB EUR 2.96B 196M 2025-12